No Data
No Data
Wakamoto Pharmaceutical: Extraordinary Report
Wakamoto Pharmaceutical: Confirmatory letter.
Wakamoto Pharmaceutical: Securities Report - 129th Fiscal Year (April 1, 2023 - March 31, 2024)
Stocks with interesting flavors seen from changes in volume, such as REMIX.
Code Closing price Change Volume <3848>Data application 1000 98 199300 <4937>Waqoo 1795 27 63500 <6190>PXB 513 25 63300 <5035>Housei 499 21 188400 <2525>NZAM 225 40460 520 5131
Wakamoto Pharmaceutical: (Correction/Numerical data correction) Partial correction of the 'March 2024 financial results briefing (Japan standard) (Non-consolidated)'.
Wakamoto Pharmaceutical FY Parent Net Y108.00M Vs Net Y138.00M
No Data